EMEGRAND 0.075MG/1.5ML VIAL FOR I.V

*It is a serotonin-3 (5-HT3) receptor antagonist indicated in adults for (Moderately to highly) emetogenic cancer chemotherapy and prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery. *It is also indicated in pediatric patients aged 1 month to less than 17 years for prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy including highly emetogenic cancer chemotherapy.